Buscar en RiuNet

Listar

Todo RiuNet

Mi cuenta

Acceder

Ayuda RiuNet

Admin. UPV

Listar por autor "Usó Talamantes, Ruth"

Mostrando ítems 1-15 de 15

Ambulatory Pharmaceutical Spending Analysis Based on Risk Stratification in Patients with Chronic Conditions

Usó Talamantes, Ruth; Trillo Mata, José Luis; Guadalajara Olmeda, María Natividad; Sancho Mestre, Carla; Vivas Consuelo, David José Juan (Elsevier, 2012-11)

Risk adjustment models allow stratifying the population, considering chronic disease as a predictor of drug costs. In this paper, we analyze outpatient drug spending using Clinical Risk Groups (CRG) to obtain patient risk ...
Análisis y desarrollo de un modelo predictivo del gasto farmacéutico ambulatorio ajustado a morbilidad y riesgo clínico

Usó Talamantes, Ruth (Universitat Politècnica de València, 2015-10-19)

[EN] Introduction: Changes in population structure, including aging, have a significant impact on chronicity, comorbidity and polypharmacy. In the field of pharmaceutical services, problems with drugs and outpatient ...
Cost of Type 2 Diabetes Patients with Chronic Kidney Disease Based on Real-World Data: An Observational Population-Based Study in Spain

Usó-Talamantes, Ruth; González-De Julián, Silvia; Díaz-Carnicero, Javier; Saurí-Ferrer, Inmaculada; Trillo-Mata, José Luis; Carrasco-Pérez, Marc; Navarro-Pérez, Jorge; Górriz, José Luis; Vivas-Consuelo, David; Redón, Josep (MDPI AG, 2021-09)

[EN] This study analyzed the prevalence, costs and economic impact of chronic kidney disease CKD in patients with T2D in a Spanish Health District using real-world data. Observational cross-sectional study in adult patients ...
Data Envelopment Analysis Applications on Primary Health Care Using Exogenous Variables and Health Outcomes

González-De Julián, Silvia; Barrachina Martínez, Isabel; Vivas-Consuelo, David; Bonet-Pla, Álvaro; Usó-Talamantes, Ruth (MDPI AG, 2021-02)

[EN] A data envelopment analysis was used to evaluate the efficiency of 18 primary healthcare centres in a health district of the Valencian Community, Spain. Factor analysis was used as a first step in order to identify ...
Evaluación de un modelo de predicción del gasto farmacéutico en atención primaria de salud basado en variables demográficas

Santamargarita Pérez, Sonia; Sancho Mestre, Carla; Vivas Consuelo, David José Juan; Usó Talamantes, Ruth (Pontificia Universidad Javeriana, Faculty of Science, 2013)

[EN] Problem: In the current context of budget constraints in the health sector management systems that allow allocating spending more efficiently are required. In the case of pharmaceutical expenditure, risk adjustment ...
Gasto farmacéutico en diabetes mellitus en una región de España según el Clinical Risk Group, 2012

Alvis, Luis; Vivas-Consuelo, David; Caballer Tarazona, Vicent; Usó Talamantes, Ruth; Sancho Mestre, Carla; Buigues Pastor, Laia (Pontificia Universidad Javeriana, 2016)

[ES] Se pretende estimar la multimorbilidad asociada con diabetes mellitus tipo 2 y su relación con el gasto farmacéutico, para lo cual se realizó un estudio de corte transversal durante el año 2012. Se identificó a 350 ...
Measurement of health-related quality by multimorbidity groups in primary health care

Milá-Perseguer, Magdalena; Guadalajara Olmeda, María Natividad; Vivas-Consuelo, David; Usó-Talamantes, Ruth (Springer (Biomed Central Ltd.), 2019-01-11)

[EN] Background: Increased life expectancy in Western societies does not necessarily mean better quality of life. To improve resources management, management systems have been set up in health systems to stratify ...
Methods to control the pharmaceutical cost impact of chronic conditions in the elderly

Vivas Consuelo, David José Juan; Usó Talamantes, Ruth; Trillo Mata, José Luis; Mendez Valera, Pablo (Expert Reviews (formerly Future Drugs), 2015-06)

Multimorbidity is the main cause of polypharmacy in elderly people, with the consequent increment in cost and use of inappropriate medication. To control cost, specific strategies have been implemented in healthcare ...
Modelling Deprivation Level and Multimorbidity in a Health District

Botija Yagüe, María Pilar; Sorbet-Santiago, Sofía; Díaz-Carnicero, Javier; González-De Julián, Silvia; Usó-Talamantes, Ruth (MDPI AG, 2022-02)

[EN] Deprivation is associated with an increased risk of developing chronic health conditions and with worse outcomes in multimorbidity. The goal of our study was to develop an integrated population index of deprivation ...
Pharmaceutical Cost Analysis of Diabetes Mellitus Using Clinical Risk Groups in Valencian Community

Romero; M.; Usó Talamantes, Ruth; Vivas Consuelo, David José Juan; De la Poza, Elena; Sancho Mestre, C.; Trillo Mata, José Luis; Barrachina Martínez, Isabel (Elsevier, 2013-11)

Metabolic agents have the highest expense (130 million Euros per year in the Valencian Community) among the top five therapeutic categories of drugs for adults aged 18 and over. Treatment of Diabetes Mellitus (DM) is the ...
Pharmaceutical cost and multimorbidity with type 2 diabetes mellitus using electronic health record data

Sancho Mestre, Carla; Vivas Consuelo, David José Juan; Alvis, Luis; Romero, Martin; Usó Talamantes, Ruth; Caballer Tarazona, Vicent (BioMed Central, 2016)

[EN] Background: The objective of the study is to estimate the frequency of multimorbidity in type 2 diabetes patients classified by health statuses in a European region and to determine the impact on pharmaceutical ...
Pharmaceutical Cost Management in an Ambulatory Setting Using a Risk Adjustment Tool

Vivas Consuelo, David José Juan; Usó Talamantes, Ruth; Guadalajara Olmeda, María Natividad; Trillo Mata, José Luis; Sancho Mestre, Carla; Buigues Pastor, Laia (BioMed Central, 2014-10-21)

Background Pharmaceutical expenditure is undergoing very high growth, and accounts for 30% of overall healthcare expenditure in Spain. In this paper we present a prediction model for primary health care pharmaceutical ...
Predictability of pharmaceutical spending in primary health services using Clinical Risk Groups

Vivas Consuelo, David José Juan; Usó Talamantes, Ruth; Trillo Mata, José Luis; Caballer Tarazona, María; Barrachina Martínez, Isabel; Buigues Pastor, Laia (Elsevier, 2014-06)

Background: Risk adjustment instruments applied to existing electronic health records and administrative datasets may contribute to monitoring the correct prescribing of medicines. Objective: We aim to test the suitability ...
Predictability of pharmaceutical spending using Clinical Risk Groups in the Valencian Community, Valencia

Usó Talamantes, Ruth; Caballer Tarazona, María; Buigues Pastor, Laia; Trillo Mata, José Luis; Guadalajara Olmeda, María Natividad; Vivas Consuelo, David José Juan (Elsevier, 2011-11)

The Valencian Community, with 5,000,000 inhabitants, is implementing a system of pharmaceutical management to reduce costs. This system is based on classifying patients in groups using the case mix system, Clinical Risk ...
Sistema de prescripción y dispensación electrónica en la Agencia Valenciana de Salud

De la Poza, Elena; Barrachina Martínez, Isabel; Trillo Mata, José Luis; Usó Talamantes, Ruth (EPI SCP, 2011)

[ES] El sistema de prescripción y dispensación electrónica supone un avance en el uso de nuevas tecnologías en el Sistema Nacional de Salud. Implica la mejora de los procesos de prescripción y dispensación farmacoterapéutica ...